Phage therapy—constraints and possibilities

Call for a Dedicated European Legal Framework for Bacteriophage Therapy

(2014) Gilbert Verbeken et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

PredictingIn VivoEfficacy of Therapeutic Bacteriophages Used To Treat Pulmonary Infections

(2013) Marine Henry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Bacteriophage Lysin with Broad Lytic Activity Protects against Mixed Infection by Streptococcus pyogenes and Methicillin-Resistant Staphylococcus aureus

(2013) Daniel B. Gilmer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular mechanisms of CRISPR-mediated microbial immunity

(2013) Giedrius Gasiunas et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Editorial Commentary: Phage Therapy: Quo Vadis?

(2013) H. Brussow   CLINICAL INFECTIOUS DISEASES

Antibacterial Bioagents Based on Principles of Bacteriophage Biology: An Overview

(2013) B. M. Knoll et al.   CLINICAL INFECTIOUS DISEASES

Lysins: the arrival of pathogen-directed anti-infectives

(2013) M. Pastagia et al.   JOURNAL OF MEDICAL MICROBIOLOGY

A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity

(2013) Kimberley D. Seed et al.   NATURE

Safety analysis of a Russian phage cocktail: From MetaGenomic analysis to oral application in healthy human subjects

(2013) Shawna McCallin et al.   VIROLOGY

Dealing with the Evolutionary Downside of CRISPR Immunity: Bacteria and Beneficial Plasmids

(2013) Wenyan Jiang et al.   PLoS Genetics

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

(2012) H-G Eichler et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Diagnosing the decline in pharmaceutical R&D efficiency

(2012) Jack W. Scannell et al.   NATURE REVIEWS DRUG DISCOVERY

Going viral: next-generation sequencing applied to phage populations in the human gut

(2012) Alejandro Reyes et al.   NATURE REVIEWS MICROBIOLOGY

Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh

(2012) Shafiqul Alam Sarker et al.   VIROLOGY

The Population and Evolutionary Dynamics of Vibrio cholerae and Its Bacteriophage: Conditions for Maintaining Phage-Limited Communities

(2011) Yan Wei et al.   AMERICAN NATURALIST

Different Classes of Antibiotics Differentially Influence Shiga Toxin Production

(2010) C. M. McGannon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phage Therapy Pharmacology

(2010) Stephen Abedon et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Phage Choice, Isolation, and Preparation for Phage Therapy

(2010) Jason Gill et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Phage Therapy in Clinical Practice: Treatment of Human Infections

(2010) Elizabeth Kutter et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy

(2009) A. Wright et al.   CLINICAL OTOLARYNGOLOGY

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

(2009) Maya Merabishvili et al.   PLoS One

The phage abortive infection system, ToxIN, functions as a protein–RNA toxin–antitoxin pair

(2009) Peter C. Fineran et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

(2009) T. K. Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

T4 phages against Escherichia coli diarrhea: Potential and problems

(2009) Emmanuel Denou et al.   VIROLOGY